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The interaction between the renal water channel aquaporin-2
(AQP2) and the lysosomal trafficking regulator-interacting pro-
tein LIP5 targets AQP2 to multivesicular bodies and facilitates
lysosomal degradation. This interaction is part of a process that
controls AQP2 apical membrane abundance in a vasopressin-
dependent manner, allowing for urine volume adjustment.
Vasopressin regulates phosphorylation at four sites within the
AQP2 C terminus (Ser256, Ser261, Ser264, and Thr269), of which
Ser256 is crucial and sufficient forAQP2 translocation fromstor-
age vesicles to the apical membrane. However, whether AQP2
phosphorylation modulates AQP2-LIP5 complex affinity is
unknown. Here we used far-Western blot analysis and
microscale thermophoresis to show that theAQP2bindsLIP5 in
a phosphorylation-dependent manner. We constructed five
phospho-mimicking mutants (S256E, S261E, S264E, T269E,
and S256E/T269E) and a C-terminal truncation mutant
(P242) that lacked all phosphorylation sites but retained a pre-
viously suggested LIP5-binding site. CD spectroscopy indicated
that wild-type AQP2 and the phospho-mimicking mutants had
similar overall structure but displayed differences in melting
temperatures possibly arising from C-terminal conformational
changes. Non-phosphorylatedAQP2 bound LIP5with the high-
est affinity, whereas AQP2-P242 had 20-fold lower affinity as
determined by microscale thermophoresis. AQP2-S256E, S261E,
T269E, and S256E/T269E all had reduced affinity. This effect
was most prominent for AQP2-S256E, which fits well with its
role in apical membrane targeting. AQP2-S264E had affinity
similar to non-phosphorylated AQP2, possibly indicating a
role in exosome excretion. Our data suggest that AQP2 phos-
phorylation allosterically controls its interaction with LIP5,
illustrating how altered affinities to interacting proteins form
the basis for regulation of AQP2 trafficking by post-transla-
tional modifications.
The human body controls blood volume and osmolality by
the vasopressin-dependent trafficking of aquaporin-2 (AQP2)2
water channels to the apical membrane of the collecting duct
principal cells (1). AQP2 trafficking involves a dynamic equilib-
rium between regulated exocytosis and endocytosis of AQP2-
containing storage vesicles. During dehydration, vasopressin,
released from the pituitary gland, binds to the V2 receptor in
the basolateral membrane and triggers a cAMP signaling cas-
cade. This ultimately results in fusion ofAQP2-containing stor-
age vesicles with the apical membrane as well as increased
AQP2 membrane retention and elevated water reabsorption
from pro-urine (2–4). After restoration of the dehydration, the
reduced vasopressin levels lead to the internalization of AQP2
through endocytosis, after which it is stored in intracellular
vesicles for another round of activation, degraded in lysosomes
or released as exosomes (5, 6).
Multiple post-translational modifications within the AQP2
C terminus regulate its subcellular localization. In human
AQP2, four phosphorylation sites have been identified: Ser256,
Ser261, Ser264, andThr269 (Ser269 inmice), all of which are phos-
phorylated in a vasopressin-dependentmanner (2–4, 7–9) (Fig.
1). Studies in mammalian cells, primarily using kinase and
phosphatase inhibitors/activators, as well as phospho-mimick-
ing mutants, have shown that Ser256 plays the most prominent
role: its phosphorylation by PKA is essential and sufficient for
vasopressin-mediated translocation of AQP2 from storage ves-
icles to the apicalmembrane (2–4). Vasopressin also stimulates
additional phosphorylation at Thr269, and this has been shown
to reduce the internalization rate, prolonging the time AQP2
resides in the apicalmembrane (8, 10, 11). The role of vasopres-
sin-mediated phosphorylation of Ser264 is unknown but has
been suggested to play a role in AQP2 sorting within the endo-
somal system and may be involved in transcytosis from the
basolateral membrane (7). In contrast, vasopressin triggers
dephosphorylation of Ser261, and AQP2 mimicking phosphor-
ylation on Ser261 only mainly resides in intracellular vesicles
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Lys270, which, when sustained, results in sorting into multive-
sicular bodies (MVBs) and subsequent lysosomal degradation
(5). Interestingly, phosphorylation of Thr269 is able to override
the ubiquitin-internalization signal (8), and phosphorylation of
Ser261 has been shown to increase ubiquitinated AQP2 levels
(13). This suggests that there is an intricate cross-talk between
the post-translational modifications that determine AQP2 api-
cal membrane abundance.
Membrane protein translocation between cellular compart-
ments depends on the interaction with proteins of the mem-
brane protein sorting and vesicular trafficking machinery.
These interactions are governed by sorting signals within the
membrane protein themselves, such as short linear sequences
or post-translational modifications (14, 15). A number of pro-
teins have been shown to interact with AQP2 and affect its
cellular localization, including members of the 70-kDa heat
shock protein family (Hsc70 and Hsp70) (16, 17), Annexin II
(18), SPA-1 (the protein encoded by the signal-induced prolif-
eration-associated gene-1) (19), and LIP5 (the lysosomal traf-
ficking regulator (LYST)-interacting protein 5) (20). Several
AQP2-interacting proteins have been shown to preferentially
interact with non-phosphorylated or phosphorylated AQP2
(11, 21, 22). It is therefore plausible that altered affinities to
interacting proteins form the rationale for how AQP2 phos-
phorylation determines its subcellular localization.
LIP5 plays an important role in MVB biogenesis where its
interaction with components of the endosomal sorting com-
plex required for transport (ESCRT)-III complex and the VPS4
ATPase helps coordinate membrane fission and ESCRT-III
complex disassembly (23–25). Interestingly, LIP5 has also been
shown to interact with membrane protein cargo, one of which
is AQP2, thereby leading to its increased lysosomal degradation
(20). VanBalkom et al. (20) demonstrated that LIP5 binds to the
proximal part of the AQP2 C terminus, corresponding to a
short C-terminal helix in its crystal structure (Fig. 1) (26), and
that the interaction occurred regardless of theAQP2phosphor-
ylation and ubiquitination status. However, because the inter-
actionwas not further quantified, it is not knownwhether post-
translationalmodifications of AQP2 result inmodulation of the
AQP2-LIP5 complex affinity.
In this work, we investigated the effect of AQP2 phosphory-
lation on the AQP2-LIP5 interaction in a quantitative manner.
To do this, we constructed phospho-mimicking mutants of
human AQP2 where the phosphorylated serine/threonine is
replaced by glutamate, a substitution that is commonly used as
a phospho-mimic (27). In addition to the singlemutants S256E,
S261E, S264E, and T269E, we alsomade a S256E/T269E double
mutant, because phosphorylation of Thr269 follows that of
Ser256. The interaction with LIP5 was studied using far-West-
ern blot and microscale thermophoresis (MST), revealing that
Figure 1. Crystal structure of humanAQP2.Cartoon representation of the 2.75 Å humanAQP2 crystal structure (ProteinData Bank code 4NEF)with residues
that could not be resolved displayed as beads. Phosphorylation and ubiquitination sites are highlighted in red and gray, respectively. The proximal part of the
C terminus that has been shown to bind LIP5 (20) forms a short helix (green).
AQP2 phosphorylation regulates affinity to LIP5
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although all AQP2 phosphorylation mutants were able to bind
LIP5, there was a significant effect on the affinity, with four of
five mutants having a higher Kd, as determined by MST. We
further show that although the distal part of theC terminus that
contains the phosphorylation sites was not critical for the
AQP2-LIP5 interaction, removal of this region resulted in
20-fold lower affinity. This suggests that the distal AQP2 C
terminus and its phosphorylation status plays an important role
in modulating the affinity to LIP5, thereby fine-tuning its sort-
ing into MVBs.
Results
Human AQP2 is phosphorylated when produced in Pichia
pastoris
Wild-type human AQP2, AQP2 phospho-mimicking mu-
tants (S256E, S261E, S264E, and T269E), and AQP2 truncated
after Pro242 (AQP2-P242) were cloned into yeast expression
vectors, overproduced in the yeast P. pastoris, and purified.
Because P. pastoris is known to be able to phosphorylate
recombinant proteins, including aquaporins (28), we decided
to investigate whether this also holds true for human AQP2.
Purified human AQP2 was run on an SDS-PAGE and probed
for phosphorylation using PhostagTM-BTL-111. As seen in Fig.
2A (lane 1), a clear signal for phosphorylation is evident for
AQP2. Three bands are observed, presumably corresponding
to theAQP2monomer, dimer, and tetramer. Threemain bands
are also seen in a Western blot stained with antibodies against
the His tag (Fig. 2B), confirming their identity as AQP2. The
apparent lower molecular mass for these bands compared with
what is expected is a common phenomenon during SDS-PAGE
analysis of membrane proteins (29).
The AQP2 phosphorylation status was further examined
using mass spectrometry, whereby purified AQP2 was sub-
jected to trypsin digestion and the peptides were analyzed by
ESI-Orbitrap. Forty unique peptides could be assigned, corre-
sponding to 38% of the amino acid sequence (Table 1). Phos-
phorylation was detected for nine of these unique peptides.
Further MS/MS analysis revealed phosphorylation at three of
four sites: Ser256, Ser261, and Ser264. Data from two representa-
tiveMS/MSanalyses,unambiguouslyassigningthesephosphor-
ylations by detecting an extra mass of 98 Da, are listed in sup-
plemental Table S1 (mass errors displayed in supplemental Fig.
S1). In the peptide 253R.RQSVELHSPQSLP.R268, all three ser-
ines were observed to be phosphorylated at the same time.
However, other combinations of phosphorylated and unphos-
phorylated serines were also present, as well as a completely
unphosphorylated peptide, showing thatAQP2whenproduced
in P. pastoris is not phosphorylated homogeneously (Table 1).
Phosphorylation of Thr269 could not be verified because of its
location at the C terminus where the tryptic digestion results in
a fragment that is too low in mass to be detected.
One additional site, Thr244, was also observed to be phos-
phorylated byP. pastoris. However, this site has not been shown
to be phosphorylated in vivo (30, 31), and there are no indica-
tions that it plays a role in vasopressin-dependent trafficking of
AQP2 (4, 32).
Phospho-mimickingmutations and phosphorylation reduce
AQP2 thermal stability
The effect of phospho-mimicking mutations on AQP2 over-
all fold and stability was studied using CD spectroscopy.
Far-UV CD spectra between 190 and 260 nm were recorded at
25 °C for wild-type AQP2 that had been dephosphorylated by
alkaline phosphatase and AQP2 phospho-mimicking mutants.
In addition, we also recorded spectra for AQP2 that had not
been treated with alkaline phosphatase and that therefore is
phosphorylated as demonstrated by mass spectrometry. All
AQP2 variants display very similar spectra with the two local
minima at 210 and 222 nm that are characteristic for -helical
proteins (Fig. 3A), indicating that the phospho-mimicking
mutations do not affect the overall fold of the protein.
The thermal stability of wild-type AQP2 and AQP2 phos-
pho-mimicking mutants was determined by recording CD
spectra at different temperatures. By plotting themean residual
ellipticity (MRE) at 222 nm against the temperature and fitting
the data to a Boltzmann sigmoidal equation, a melting curve is
obtained from which melting temperature (TM) can be calcu-
lated (Fig. 3, B and C). Dephosphorylated AQP2 exhibited the
highest stability with a TM of 83.5  2.00 closely followed by
AQP2-T269E (TM 79.2 1.90) (Fig. 3,B andD). The stability
was further reduced for AQP2-S264E and AQP2-S261E, for
which TMwas 74.06 1.56 and 73.67 1.58. AQP2 S256E had
the lowest stability, with a TM of 70.07  1.52. AQP2-S256E/
T269E displayed a TM of 73.23 1.95, in between those of the
single S256E and T269E mutants.
Similar to the AQP2 phospho-mimicking mutants, un-
treated AQP2, which is phosphorylated by P. pastoris during
expression, has a markedly lower stability than dephosphory-
lated AQP2 (TM 74.5 1.65) (Fig. 3, C andD). Furthermore,
the data points for non-treated AQP2 does not fit equally well
to the expected Boltzmann sigmoidal equation, in particular in
the 20–60 °C range. This may be because this sample repre-
sents AQP2 in a variety of phosphorylation states with different
Figure 2. Phosphorylation of AQP2 in P. pastoris. A, purified AQP2 pro-
duced in P. pastoris was transferred to a PVDF membrane and probed for
phosphorylation using Phos-tag BTL-111. A clear phosphorylation signal is
seen for non-treated AQP2 (lane 1) with bands corresponding to monomeric
(30 kDa), dimeric (60 kDa), and tetrameric (120 kDa) forms of the protein.
Following treatmentwith alkaline phosphatase for 2, 4, and 20h (lane 2-4), no
bands can be seen, illustrating complete removal of phosphorylation. B,
Western blot stained with antibody against the His tag shows that equal
amount of AQP2 is present in all samples. Protein bands corresponding to
those seen in A are marked with arrows. Protein masses are indicated in kDa.
AQP2 phosphorylation regulates affinity to LIP5
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Figure 3. CD spectroscopy and thermal stability of AQP2 andAQP2mutants.A, far-UV CD spectra for non-treatedwild-type AQP2 (nt AQP2), dephosphor-
ylated wild-type AQP2 (dep AQP2), and dephosphorylated AQP2 phosphorylation mutants (S256E, S261E, S264E, T269E, and S256E/T269E). B, melting curves
for dephosphorylatedAQP2 andAQP2phosphorylationmutants. The curves are obtainedbyplotting theMRE at 222nm fromCDspectra obtained at different
temperatures. C, melting curves as in B for non-treated wild-type AQP2, dephosphorylated wild-type AQP2, and AQP2-S256E. The melting curve for non-
treated AQP2 ismore similar to AQP2-S256E than to dephosphorylated AQP2.D, bar chart displayingmelting temperatures for the different AQP2 constructs.
All phosphorylation mutants have a significantly lower TM than dephosphorylated AQP2 (*** indicates p 0.001, and ** indicates p 0.01; NS indicates not
significant).
Table 1
Mass spectrometry analysis of AQP2 phosphorylation
All identified peptides assigned to AQP2. Peptide start and end numbering includes the N-terminal His tag. Phosphorylated residues are indicated in bold type. Mr
(calculated) indicates the theoretical monoisotopic mass of neutral peptide; ppm, mass accuracy;M, number of missed cleavages.
Start End
Mr
(calculated) Peptide sequence Phosphorylation
No. of
peptides Charge ppm range M
Da
94 121 2821.5490 R.AAFYVAAQLLGAVAGAALLHEITPADIR.G 13 3, 4, 5 1.35–6.41 0
196 205 941.5546 R.SLAPAVVTGK.F 6 2 2.41–7.23 0
196 236 4470.4184 R.SLAPAVVTGKFDDHWVFWIGPLVGAILGSLLYNYVLFPPAK.S 5 4 0.35–5.92 1
206 336 3546.8744 K.FDDHWVFWIGPLVGAILGSLLYNYVLFPPAK.S 12 4, 5 0.72–3.85 0
242 257 1869.9472 R.LAVLKGLEPDTDWEER.E 4 3 1.27–6.94 1
247 257 1345.5786 K.GLEPDT244DWEER.E 8 2 4.28–6.02 0
247 257 1425.5449 K.GLEPDT244DWEER.E T244 5 2 3.67–7.08 0
247 260 1729.7907 K.GLEPDT244DWEEREVR.R 6 2, 3 1.82–5.26 1
247 260 1809.7570 K.GLEPDT244DWEEREVR.R T244 3 2 3.14–5.28 1
262 275 1632.8696 R.RQS256VELH S261PQS264LPR.G 8 2, 3, 4 0.27–4.40 1
262 275 1712.8359 R.RQS256VELHS261PQS264LPR.G S256 13 2, 3 1.10–5.82 1
262 275 1712.8360 R.RQS256VELH S261PQS264LPR.G S261 2 4 5.11 1
262 275 1792.8023 R.RQS256VELH S261PQS264LPR.G S256, S261 7 2, 4 2.40–5.10 1
262 275 1872.7686 R.RQS256VELH S261PQS264LPR.G S256, S261, S264 4 2 3.61–4.93 1
263 275 1476.7685 R.QS256VELHS261PQS264LPR.G 22 2, 3 (4.52)6.96 0
263 275 1556.7348 R.QS256VELHS261PQS264LPR.G S261 9 2, 3 (3.68)3.90 0
263 275 1636.7011 R.QS256VELHS261PQS264LPR.G S261, S264 2 2 1.30–1.32 0
263 275 1636.7011 R.QS256VELHS261PQS264LPR.G S256, S261 5 2, 4 3.04–5.30 0
AQP2 phosphorylation regulates affinity to LIP5
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melting behaviors. A deviation from sigmoidal behavior in a
similar temperature range is also seen for dephosphorylated
AQP2 and the phospho-mimicking mutants (Fig. 3C and sup-
plemental Fig. S2), although to a smaller extent. This could be
interpreted as a minor transition representing an unfolding
event prior to the major transition, possibly of flexible regions
such as the termini. In this respect, it is interesting to note that
this minor transition varies somewhat in extent and tempera-
ture range between the different phosphorylation mutants
(supplemental Fig. S2), suggesting phosphorylation-induced
differences in the structure of the C terminus.
Phospho-mimickingmutations and C-terminal truncation
affects the interaction between AQP2 and LIP5
The interaction between AQP2 and LIP5 and its dependence
on phosphorylation and C-terminal truncation was initially
explored using the far-Western blot technique (33). To ensure a
phosphorylation-free background, all AQP2 constructs were
dephosphorylated after purification, with the exception of
AQP2-P242 in which phosphorylation sites are removed by
truncation. Incubation of purified AQP2 with alkaline phos-
phatase for 2 h resulted in complete dephosphorylation, as
illustrated in Fig. 2A (lane 2). AWestern blot stained with anti-
bodies against the His tag confirms that AQP2 is present in the
dephosphorylated sample (Fig. 2B, lanes 2–4). The dephos-
phorylated proteins were additionally purified using size exclu-
sion chromatography prior to further studies.
Equal amounts of purified wild-type AQP2, AQP2 phospho-
mimicking mutants (S256E, S261E, S264E, T269E, and S256E/
T269E), AQP2-P242, and human AQP4 (negative control)
were run on an SDS-PAGE gel, transferred to a nitrocellulose
membrane, denatured with guanidine HCl, and re-natured,
thereby regaining their native secondary and tertiary structure.
After blocking and incubation with LIP5 overnight, the AQP2-
LIP5 interaction was probed using an antibody directed against
LIP5 (20).
As seen in Fig. 4A, LIP5 interacts with wild-type AQP2,
whereas no interactionwas observedwith AQP4. Furthermore,
although all phospho-mimicking mutants show a positive sig-
nal for LIP5 interaction, there is a distinct variation in the signal
strength. Staining with antibody directed against the His tag
(Fig. 4B) and Ponceau reagent (Fig. 4C) showed that protein
equivalents had been loaded, illustrating that the observed sig-
nal strength variation was not due to differences in protein
amounts. Quantification of the signal relative to wild-type
AQP2 (Fig. 4D) revealed that AQP2-S256E, AQP2-S261E, and
AQP2-S264E show reduced binding, equivalent to 55  1.2,
63  3.5, and 59  2.5% of the wild-type signal, respectively.
The signal for AQP2-T269E ismore similar to wild-type AQP2,
the relative intensity is 80  12%. The double AQP2-S256E/
T269E mutant behaved similarly as the single mutant AQP2–
256E with relative intensity signal of 54  6.4%. Interestingly,
AQP2 lacking the distal part of the C terminus containing the
phosphorylation sites (AQP2-P242) yielded in the lowest
interaction signal corresponding to 22  5.9% of wild-type
AQP2. This suggests that the distal C terminus and its phos-
phorylation statusmodulate the interaction betweenAQP2 and
LIP5.
AQP2-S256E, S261E, T269E, S256E/T269E, andP242 have
significantly lower affinity to LIP5 thanwild-type AQP2
The effect of phosphorylation on the AQP2-LIP5 interaction
was further studied by determining complex affinities using
MST, a method that detects complex formation from a change
of movement in a thermal gradient. As for the far-Western
blot analysis, wild-type AQP2 and AQP2 phospho-mimicking
mutants were dephosphorylated prior to the experiment. For
each protein, a 1.5-fold (wild-type AQP2 and AQP2 phospho-
mimicking mutants) or 2-fold dilution series (AQP2-P242
and AQP4) was made, resulting in 16 different samples. Each
sample was mixed 1:1 with a constant concentration of LIP5,
fluorescently labeled with the amine-reactive dye (NT-647-
NHS), and MST traces were recorded (supplemental Fig. S3).
This resulted in a binding curve from which the dissociation
constant Kd could be determined (Fig. 5 and supplemental Fig.
S4).
Non-phosphorylated wild-type AQP2 binds LIP5 with a Kd
of 191 43.2 nM (Fig. 5,A andD). For AQP4 there is a variation
in fluorescence signal (Fnorm); however, the data points are
scattered, and saturation is never reached. Hence, the data can-
not be fitted to a binding curve, wherefore we conclude that the
data do not describe a concentration-dependent interaction
between AQP4 and LIP5. This is further supported by the far-
Western blot in which LIP5 did not bind to AQP4 (Fig. 4).
As seen in Fig. 5B, removing the distal part of the C terminus
significantly reduces the affinity: the Kd for the interaction
between AQP2-P242 and LIP5 is almost 20-fold higher than
forwild-typeAQP2 (Kd 3.63 0.44M) (Fig. 5D). Four of five
AQP2phospho-mimickingmutants bindLIP5with lower affin-
ity than wild-type AQP2 (Fig. 5, C andD). The lowest affinity is
seen for AQP2-S256E (Kd  1.00  0.25 M), the protein that
mimics AQP2 phosphorylated at themost crucial site for apical
membrane targeting. The affinity is also significantly lower for
AQP2-S261E (Kd 745 141 nM), AQP2-T269E (Kd 721
55.0 nM), and AQP2-S256E/T269E (652.7 62.2 nM), whereas
AQP2 S264E binds LIP5 with almost the same affinity as non-
phosphorylated wild type (Kd 278 49.1 nM).
Plotting log Kd against 1/TM for wild-type AQP2 and phos-
pho-mimicking AQP2 mutants reveals a linear relationship
(Fig. 6). This suggests an empirical correlation between LIP5
affinity and AQP2 stability where AQP2-S256E, the mutant
with the lowest LIP5 affinity, also has the lowest thermal stabil-
ity. The correlation seems to be weaker for the more distal
mutation sites S264E and T269E, whereas the double S256E/
T269E mutant behaves according to linearity.
The distal AQP2 C terminus does not interact with the AQP2
LIP5 binding site or with LIP5
One possible explanation for the lower affinity between LIP5
andAQP2phospho-mimickingmutants couldbe that thephos-
phorylated distal AQP2 C terminus interacts with the LIP5
binding site within the proximal AQP2 C terminus (Fig. 1),
thereby preventing the interaction. To investigate this scenario,
we used MST to study whether peptides corresponding to the
distal AQP2 C terminus (residues 244–271) phosphorylated at
Ser256, Ser261, Ser264, and Thr269, respectively, are able to inter-
AQP2 phosphorylation regulates affinity to LIP5
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act with AQP2 itself. For this experiment, a 1.5-fold dilution
series was made of each peptide, resulting in 16 samples that
were mixed 1:1 with wild-type AQP2 that had been fluores-
cently labeled with the cysteine-reactive dye Alexa-488, and
MST traces were recorded (supplemental Fig. S5A). The final
concentration of AQP2 in all samples was 500 nM. As shown in
supplemental Fig. S6, no interaction with full-length AQP2
could be observed for any of the phosphorylated peptides.
Next, we used MST to study whether the unphosphorylated
or phosphorylated distal C terminus could interact with LIP5
on its own. Similar as above, a 2-fold dilution series of the phos-
phorylated AQP2 C-terminal peptides, as well as the corre-
sponding unphosphorylated peptide, was mixed 1:1 with fluo-
rescently labeled LIP5 at a final concentration of 45 nM, and
MST traces were recorded (supplemental Fig. S5B). Neither the
unphosphorylated nor the phosphorylated distal C terminus
Figure 4. Far-Western blot analysis of the interaction between AQP2 and LIP5. Equal amounts of dephosphorylatedwild-type AQP2, AQP2mutants, and
AQP4were transferred to a nitrocellulosemembrane and incubated with purified LIP5. The interaction was detected using an antibody directed against LIP5.
A, typical far-Western blot showing that wild-type AQP2, but not AQP4, interacts with LIP5. AQP2-S256E, S261E, S264E, T269E, S256E/T269E, and P242 all
interactwith LIP5but show significant variation in signal strength. B andC, staining themembranewith antibodies against theHis tag (B) andPonceau reagent
(C) confirmed that protein equivalents had been loaded in each lane. AQP2-P242 does not contain a His tag and is consequently not stained with anti-His
antibodies (B). Marker protein masses are indicated in kDa. D, relative intensities of far Western blot signal for AQP2 mutant constructs and AQP4 compared
with wild-type AQP2 (set as 100%). The values were calculated from three independent blots. The AQP2 variants S256E, S261E, S264E, and S256E/T269E show
significantly less binding than wild-type AQP2 (p  0.001, indicated by ***) but were not significantly different from each other. The binding was further
reduced forP242 (p 0.001), whereas the signal intensity of AQP2 T269Ewasmore similar towild-type (p 0.01, indicated by **). AQP4 did not interactwith
LIP5 (p 0.001).
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interacted with LIP5 (supplemental Fig. S7). Taken together,
these experiments show that AQP2 phosphorylation does not
reduce LIP5 affinity by blocking the binding site on either
AQP2 or LIP5 and that the distal C terminus does not bind LIP5
independently.
Discussion
Protein-protein interactions lie at the heart of intracellular
membrane protein trafficking, governing recruitment of mem-
brane protein cargo to specific transport vesicles and directing
these vesicles to the correct membrane domain at the correct
time (14, 15). Because vasopressin-mediated phosphorylation
is known to regulate AQP2 endo- and exocytosis (2–4, 7–10),
this likely relies on changed affinities between phosphorylated
AQP2 andmembers of the membrane protein sorting and traf-
fickingmachinery. Indeed, several proteins have been shown to
preferentially interact with unphosphorylated or phosphorylated
AQP2 (11, 22). However, most of these studies are based on co-
immunoprecipitation, yeast two-hybrid assays, ormass spectrom-
etryandare thereforeunlikely tocatch thedynamicregulation that
more subtle differences in affinities are able to confer.
The interaction between AQP2 and LIP5 was first demon-
strated using a yeast two-hybrid assay in which the C-terminal
tail of AQP2 had been fused to LexA (20). Using a colony-based
Figure 5. Phosphorylationmodulates the affinity betweenAQP2 and LIP5. The interaction between LIP5 andAQP2wasmeasuredwithMST, and the data
were fitted according to a one-to-one binding model. A, dephosphorylated WT AQP2 interacts with LIP5 (Kd 191 43.2 nM). The data for AQP4 (negative
control) had a low amplitude, could not be fitted to the equation, and did not reach saturation; therefore binding was interpreted as non-significant. B,
C-terminal truncation of AQP2 (P242) reduces the affinity 20-fold (Kd 3.63 0.44M). C, comparison of MST curves for WT AQP2 and phospho-mimicking
mutants. There is a significant difference between WT and S256E (Kd  1.00  0.25 M), S261E (Kd  745  141 nM), T269E (Kd  721  55.0 nM), and
S256E/T269E (652.7 62.2 nM) (*, p 0.05; **, p 0.01; ***, p 0.001). There is no significant difference betweenWT and S264E (Kd 278 49.1 nM). D, bar
chart summarizing Kd values determined in A–C.
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-galactosidase assay, it was concluded that AQP2 binds LIP5
via residues Leu230–Asp243, because truncation beyond Leu230
abolished binding, whereas truncation beyond Asp243 did not.
Sequence analysis reveals that this region contains a motif,
LSERLAVLK, perfectly matching the MIM1 (MIT-interacting
motif 1) core sequence LXXRLXXL(K/R) (where  is any
hydrophobic residue, most often Leu) (34). A MIM1 motif has
previously been shown to mediate interaction between a com-
ponent of the ESCRT-III complex (CHMP1B) and the LIP5
N-terminalMIT domain (24). In the crystal structure of human
AQP2, the samemotif was involved in protein-protein interac-
tions between symmetry-related AQP2molecules in the crystal
packing (26), possibly mimicking how AQP2 interacts with
LIP5. Here, we show that AQP2-P242 binds LIP5 directly,
thereby supporting earlier data showing that the distal part of
the C terminus is not essential for the ability of AQP2 to inter-
act with LIP5 (20). However, truncation beyond Pro242 signif-
icantly reduces the affinity, suggesting that the distal C termi-
nus somehow affects LIP5 binding. Whether this involves
direct binding between the distal C terminus and LIP5 remains
to be elucidated. Our experiment showing that a peptide corre-
sponding to the distal AQP2 C terminus does not bind LIP5 on
its own (supplemental Fig. S7) suggests that if they do interact,
this is dependent on the interaction between LIP5 and the
MIM1 motif within the proximal AQP2 C terminus. Alterna-
tively the distal C terminusmay not be directly involved in LIP5
binding; instead its presence may affect the overall structure of
the C terminus and/or its position relative to the tetramer.
Although the details of how the distalAQP2C terminus plays
a role in LIP5 binding is not known, we show that introducing
phospho-mimickingmutations at four known phosphorylation
sites within this region modulates the interaction between
AQP2 and LIP5. Our far-Western blot and MST analysis of
interaction between AQP2 and LIP5 are in good agreement,
with two exceptions: AQP2-S264E and AQP2-T269E. AQP2-
S264E displays a low interaction signal in the far-Western blot
(Fig. 4), whereas the Kd determined by MST is similar to wild-
type AQP2 (Fig. 5, C and D). In the case of AQP2 T269E, the
situation is opposite; Kd is higher than for wild-type AQP2,
suggesting lower affinity, whereas the far-Western blot signal is
not significantly different. These discrepancies may arise from
method differences, such as the fact that in far-Western blot,
the proteins are immobilized, whereas in MST they are in free
solution. The crystal structure of AQP2 showed that the C termi-
nus is capable of adopting several different positions relative to the
tetramer, highlighting a flexibility that had not previously been
observed in eukaryoticAQPs (26). If theC-terminal position plays
a role in determining the affinity between AQP2 and LIP5, this is
muchmore likely to bepickedup inMST than in far-Westernblot
and could explain the differences observed here.
Our data suggest that phosphorylation of AQP2 serves as an
allosteric trigger, affecting the interaction with LIP5 by induc-
ing conformational changes within the C terminus ormodulat-
ing binding to a secondary binding site within LIP5. Phospho-
rylation-induced structural changes of the C terminus could
explain the correlation between AQP2 thermal stability and
LIP5 affinity (Fig. 6), assuming that CD detects these changes.
Previous work by Zwang et al. (22) supports this, showing that
an AQP2 C-terminal peptide phosphorylated on Ser256 is less
-helical than its non-phosphorylated counterpart, whereas an
AQP2 C-terminal peptide phosphorylated on Ser261 had an
-helical content somewhere in between. This fits with our
results: AQP2-S256E has the lowest affinity and stability,
whereasAQP2-S261Ehas the second to lowest. The correlation
between stability and affinity seems to be weaker for the more
distal mutation sites S264E and T269E. However, although the
single T269Emutant deviates from linearity, the double S256E/
T269E mutant does not. Because phosphorylation of S256E
precedes phosphorylation of T269E, this represents an AQP2
phosphorylation state that is more likely to exist in the cell.
Thus, the only physiologically relevant phospho-mimicking
mutant that does not fit into the linear relationship between
affinity and stability is AQP2-S264E. It is interesting to note
that for this mutant (as well as for AQP2-T269E), the far-West-
ern blot and MST showed different results in binding activity
when compared with wild-type AQP2. We speculate that this
may reflect differences in the type of structural perturbations
caused by the phospho-mimickingmutations. For example one
mutationmay cause a loss of helical structure of theC terminus,
as suggested above for S256E and S261E, whereas another
mainly affects its position relative to the tetramer. Although
both structural perturbations might reduce LIP5 affinity to a
similar extent, their differences in overall structure could be
reflected in thermal stability.
Based on what is known about the roles of AQP2 phosphor-
ylation sites in the cell and the established role of LIP5 in tar-
geting AQP2 toMVBs, we propose the following hypothesis for
how phosphorylation-regulated interactions with LIP5 affect
AQP2 sorting in vivo (Fig. 7). In unstimulated conditions,
AQP2 is phosphorylated at Ser261 and kept in storage vesicles.
Tomaintain this intracellular pool of AQP2, the affinity to LIP5
is low. Vasopressin-mediated phosphorylation at Ser256 further
reduces the affinity to LIP5, ensuring that AQP2 is efficiently
translocated to the apical membrane. Once at the apical mem-
brane, additional phosphorylation of Thr269 reduces AQP2
internalization, increasing the AQP2 apical membrane
amount. Phosphorylation of this residue also reduces AQP2
affinity to LIP5. The highest LIP5 affinity is seen for non-
phosphorylated AQP2, suggesting that this form of the protein
Figure6.LIP5affinitycorrelateswithAQP2stability.Plotting thedissociation
constant (log Kd) for the interaction betweenAQP2 variants and LIP5 against the
inverted AQP2 melting temperature (1/TM) reveals a linear relationship (R
2 
0.4369). The correlation isweaker for themoredistalmutation S264E and T269E,
whereas the double S256E/T269Emutant fits well to the linearity.
AQP2 phosphorylation regulates affinity to LIP5
J. Biol. Chem. (2017) 292(35) 14636–14648 14643
 at RA
D
BO
U
D
 U
N
IV
ERSITEIT N
IJM
EG
EN
 on January 11, 2018
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
is targeted to MVBs for subsequent degradation in the lyso-
some. Interestingly, our data suggest that the affinity between
LIP5 and AQP2 phosphorylated at Ser264 is almost as high as
seen for non-phosphorylated AQP2. Ser264 phosphorylation is
believed to be involved in intracellular sorting of AQP2 and has
been suggested to play a role in AQP2 excretion via exosomes
(7). Because exosomes originate from the internal vesicles of
MVBs (6), our datamay indicate that Ser264 phosphorylation of
AQP2 increases the targeting of AQP2 to exosomes by increas-
ing its affinity for LIP5.
In summary, the results presented here show, for the first
time, that AQP2 phosphorylation regulates its interaction with
the lysosomal sorting protein LIP5. Importantly, we use puri-
fied full-length proteins to quantitatively investigate direct
interactions, thereby allowing us to describe a highly dynamic
process in which the distal C terminus allosterically regulates
the interaction with LIP5 in a phosphorylation-dependent
manner. Further investigations of how post-translational mod-
ifications affect the interaction betweenAQP2 and LIP5, as well
as other proteins, will give detailed knowledge of how protein-
protein interactions govern AQP2 sorting and provide a plat-
form by which structural studies of AQP2-interaction protein
complexes can be explored.
Experimental procedures
Cloning and expression of LIP5
Full-length mouse LIP5 was amplified by PCR from
pCDNA3 encoding a previously described LIP5 construct (20)
using 5-GATTTGTTATTCCATATGGCCGCGCTGGCCC-
CTCTGCCG-3 (sense) and 5-CTTGGATCCTTAATGA-
TGATGATGATGATGACCCTGAAAATACAAGTTTTCGG-
TAGTTGGGATATCGTAATCCTCCCTGCCTGTGGT-
CAGCAG-3 (antisense) as forward and reverse primers,
respectively. NdeI and BamHI restriction sites used for cloning
into the pET3a vector (Novagene) are underlined. The encoded
LIP5 product contains a C-terminal His6 tag preceded by a
tobacco etch virus (TEV) protease cleavage site (ENLYFQG). A
seven-amino acid spacer (DYDIPTT) is included between the
last residue of LIP5 and the TEV site to ensure efficient proteo-
lytic cleavage.
LIP5 was expressed in BL21* (DE3) Escherichia coli (Invitro-
gen). The cells were grown in LB media containing 50 g/ml
ampicillin. On reaching mid-log phase at an approximate A600
of 0.8, the cells were induced with 0.5 mM isopropyl -D-1-
thiogalactopyranoside for an additional 3.5–4 h. The cells were
then harvested at 6000	 g for 15 min.
Purification of LIP5
4 g of cells were resuspended in 50 ml of lysis buffer (20 mM
Tris, pH 8, 250 mM NaCl, 5% glycerol, 10 mM imidazole) sup-
plemented with one cOmpleteTM EDTA-free protease inhibi-
tor mixture tablet (Roche). The cells were lysed using 10 	
1-min sonication with 1-min intervals while being kept on ice.
Unbrokenmaterial was pelleted at 18,000	 g at 4 °C for 30min,
and the cell lysate was filtered before loading onto a 5-ml Ni2-
nitrilotriacetic acid-affinity column equilibrated with lysis
buffer. After two wash steps with lysis buffer containing 30 and
100 mM imidazole, respectively, LIP5 was eluted with the same
buffer containing 250 mM imidazole. The samples were ana-
lyzed on SDS-PAGE, and the fractions corresponding to LIP5
Figure7.Model for the roleofAQP2phosphorylation in regulatingLIP5-mediatedtargetingtoMVBs.Redandgreenboxes indicatephosphorylation sites
with decreased and increased affinity to LIP5, respectively. During unstimulated conditions, AQP2 resides in storage vesicles and ismainly phosphorylated on
Ser261. Dephosphorylation of Ser261 and phosphorylation of Ser256 trigger targeting of AQP2 to the apical membrane, whereas additional phosphorylation at
Thr269 further increases the AQP2 apical membrane residence time. Phosphorylation at these three sites reduces LIP5 affinity. Dephosphorylation, as well as
ubiquitination of AQP2, in the apicalmembrane induces endocytosis. Dephosphorylated AQP2 has the highest affinity for LIP5, stimulating its sorting into the
inner vesicles of MVBs by coordinating the actions of ESCRT-III complex and VPS4. AQP2 phosphorylated at Ser264 also has higher affinity for LIP5 andmay be
involved in sorting AQP2 into MVBs for secretion in exosomes.
AQP2 phosphorylation regulates affinity to LIP5
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were pooled and concentrated using a 10-kDa molecular mass
cutoff Vivaspin concentration tube (GE Healthcare). LIP5 was
further purified from the concentrated sample by size exclusion
chromatography, using a Superdex 200 10/300 GL column (GE
Healthcare) and LIP5 buffer (20mMTris, pH 8, 150mMNaCl, 1
mM DTT). Fractions containing LIP5 were analyzed for purity
using SDS-PAGE, pooled, and concentrated as above. The sam-
ple was used directly or supplemented with glycerol (10% final
concentration), flash-frozen in liquid nitrogen, and stored at
80 °C.
Cloning, expression, and purification of AQP2, AQP2mutants,
and AQP4
Full-length human AQP2, AQP2-P242, and human AQP4
were expressed inP. pastoris as described (26). BothAQP2 con-
structs contain aN-terminalHis8 tag, whereasAQP4 contains a
C-terminal His8 tag. AQP2-P242 also contains a TEV site
immediately following theHis tag, whereas this is not present in
full-length AQP2. AQP2 phosphorylation mutants (S256E,
S261E, S264E, and T269E) were generated using a standard
PCRmutagenesis protocol (QuikChange; Agilent). The S256E/
T269E mutant was created using a megaprimer mutagenesis
protocol as described in Tseng et al. (35). Briefly, the cells were
grown in a 3-liter fermentor (Belach, Bioteknik), and protein
expressionwas induced usingmethanol for 24–36 h. Routinely,
50–100 g of cells were lysed by 12 	 30-s bead beating cycles
with 30 s of waiting in between each cycle. The cell lysate was
centrifuged at 10,000	 g for 40 min to remove unbroken cells
and cell debris, after which membranes were isolated from the
supernatant by ultracentrifugation at 100,000 	 g for 1 h. The
membranes were homogenized and washed twice, first using
wash buffer (5 mM Tris-HCl, pH 9.5, 4 M urea, 2 mM EDTA)
followed by membrane buffer (20 mM Tris-HCl, pH 8, 20 mM
NaCl, 10% glycerol) supplemented with 1 mM PMSF and 2 mM
EDTA. Themembranes were finally resuspended inmembrane
buffer to a final concentration of 0.5 g/ml and stored at80 °C
until further use.
The membranes were diluted 1:1 with 25 ml solubilization
buffer (20mMTris-HCl, pH 8, 300mMNaCl, 4% octyl glucoside
neopentyl glycol (OGNPG; Anatrace) supplemented with one
cOmpleteTM EDTA-free protease inhibitor mixture tablet
(Roche) with continuous stirring for 1 h at 4 °C. Final solubili-
zation volume and detergent concentration was 50 ml and 2%,
respectively. Unsolubilized material was pelleted at 100,000 	
g. The supernatant was supplemented with imidazole to a final
concentration of 10 mM and loaded on a nickel-affinity column
(HisTrap, GE Healthcare) equilibrated with AQP2 buffer (20
mM Tris-HCl, pH 8, 300 mM NaCl, 10 mM imidazole, 0.2%
OGNPG). After washing with the same buffer containing 75
mM imidazole, AQP2was eluted using 300mM imidazole. Frac-
tions were analyzed using SDS-PAGE, pooled, and concen-
trated using a Vivaspin concentrator with 50-kDa cut-off. The
concentrated sample was loaded on a Superdex 200 10/300 GL
(GEHealthcare) equilibrated with the AQP2 buffer. After SDS-
PAGE analysis, relevant fractions were pooled and concen-
trated as above.
For AQP2-P242 the His tag was removed as an additional
purification step prior to gel filtration. Following elution from
the nickel-affinity column, the imidazole was removed by
desalting to AQP2 buffer on a PD-10 column (GE Healthcare).
The protein was incubated with TEV protease (35) in a 1:2
AQP2:TEV protease ratio. The sample was supplemented with
0.5 M TCEP and incubated on a rotating table at 4 °C, over-
night. Precipitate was removed with a 0.45-m syringe filter,
and the sample was loaded on a nickel-affinity column equili-
brated with AQP2 buffer supplemented with 20 mM imidazole.
The flow-through was collected, concentrated, and further
treated as the other AQP2 constructs.
AQP4 was purified similarly to AQP2 but with the following
alterations: The membranes were solubilized in 20 mM Tris-
HCl, pH 8, 300 mM NaCl, 10% glycerol, 4% -octyl glucoside
supplemented with one cOmplete protease inhibitor tablet for
2.5 h at 4 °C. Nickel-affinity chromatography was performed in
20 mM Tris-HCl, pH 8, 300 mM NaCl, 10% glycerol, 1% -octyl
glucoside. The column was washed with the same buffer sup-
plemented with 75 mM imidazole and protein eluted using 300
mM imidazole. AQP4 was further purified by SEC using an
Enrich 650 10 	 300 (Bio-Rad) in 20 mM Tris-HCl, pH 8, 300
mM NaCl, 0.2% OGNPG.
Dephosphorylation
Purified AQP2 was treated with alkaline phosphatase in 5
mM Tris-HCl, pH 7.9, 10 mM NaCl, 1 mM MgCl2, and 0.1 mM
DTT and incubated at 30 °C for different time interval of 2, 4,
and 20 h. For Far Western blot and MST experiments, wild-
type AQP2 and AQP2 phospho-mimicking mutants were
treated with alkaline phosphatase for 2 h and subsequently
purified using size-exclusion chromatography as described
above.
Phosphorylation analysis
Untreated and dephosphorylated AQP2 were probed for
phosphorylation using a biotinylated phosphate binding tag
(Phos-tagTM BTL-111; Wako Pure Chemical Industries, Ltd).
The experimental procedure implemented is described in detail
by Kinoshita et al. (36) with slightmodification asmentioned in
Ampah-Korsah et al. (28). Briefly, equal amounts of untreated
and treated AQP2 were run on an SDS-PAGE gel, after which
the proteins were transferred onto a PVDFmembrane for 1 h at
100 V. The membrane was blocked with 10% (w/v) BSA in
TBS-T for 6 h followed by overnight incubation with a complex
between Phos-tag BTL-111 and streptavidin-conjugated horse-
radish peroxidase (HRP-SA) to detect protein phosphorylation.
ThePhos-tagBTL-111/HRP-SAcomplexwas prepared bymix-
ing 5 l of 10 mM aqueous solution of Phos-tag BTL-111, 20 l
of 10 mM aqueous solution of Zn(NO3)2, 1 l of HRP-SA (GE
Healthcare Biosciences), and 469l of TBS-T (10mMTris-HCl,
pH7.5, 100mMNaCl, 0.1%Tween20) followedby incubation in
the dark for 1 h at room temperature. The mixture was then
transferred into a 30 K Nanosep filtration column (Pall Corpo-
ration) and spun for 6 min at 14,000 	 g to remove excess
Phos-tag BTL-111. The remaining solution (
10 l) was
diluted with 25 ml of TBS-T solution containing 1% (w/v) BSA
and 1 M sodium acetate and used for incubation as described
above. The membrane was washed twice, 5 min/wash with
TBST containing 1% (w/v) BSA and 1 M sodium acetate. The
AQP2 phosphorylation regulates affinity to LIP5
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blot was developed using ECl chemiluminescence (GE
Healthcare).
For the control blot stained with an antibody against the His
tag, equal amounts of untreated and treated AQP2 were run on
an SDS-PAGE gel, after which the proteins were transferred
onto a PVDF membrane for 1 h at 100 V. The membrane was
treated in a similar way as for the phosphorylation analysis blot,
where the membrane was blocked with 10% (w/v) BSA in
TBS-T for 6 h followed by overnight incubation with anti-His
antibody (His6 monoclonal antibody, 631212 (albumin free),
Clontech), diluted 1:5000 in 5% milk in TBS-T for 1 h. After
washing three times for 5 min each, the membrane was incu-
bated with a secondary antibody (anti-mouse IgG, 374-1806;
Kirkegaard and Perry Laboratories) diluted 1:5000 in 5%milk in
TBS-T for 1 h. Finally, the membrane was washed three times
for 5 min in TBS-T and developed using ECL chemilumines-
cence (GE Healthcare).
Mass spectrometry sample preparation and data collection
Purified full-length AQP2 was first treated with iodoacet-
amide to alkylate cysteines (19, 37). Afterward the protein sam-
ple was denatured using a solution containing 6 M urea and
sequentially digested with LysC and trypsin or not denatured
and digested with trypsin only. The resulting peptides were
purified using C18 microcolumn and separated using online
reversed phase nano-LC system.Mass spectrometry analysis of
the protein was done using LTQOrbitrap Velos Promass spec-
trometer (Thermo Fisher Scientific), coupled with a nanoEasy
spray ion source (Proxeon Biosystems).
Mass spectrometry data analysis
Peak picking was performed by Mascot Distiller version
2.6.1.0 using default settings. A peptidemass fingerprint search
in Mascot Daemon version 2.5.1 using our own database with
AQP2 sequence resulted in 38% protein sequence coverage
(p  0.05). The peptide mass tolerance was  10 ppm, and a
maximum of one missed cleavage was allowed. Phosphoryla-
tion on serine or threonine was added to the search as variable
modification. 40 non-duplicate peptides were identified and
confirmed by MS/MS. For MS/MS search, the mass tolerance
was set to 0.5 Da.
CD spectroscopy and data analysis
Briefly, purified non-treated and dephosphorylated wild-
type AQP2 and AQP2 phospho-mimicking mutants were
diluted with 10 mM potassium phosphate, pH 7.5, 100 mM
NaCl, 0.2% OGNPG, 5% glycerol to a final concentration of 0.2
mg/ml. The protein solutionwas added to a quartz cuvette with
0.1-cmpath length, and the farUVCD spectra between 260 and
190 nm were obtained in Jasco J-720 spectrometer (Jasco,
Tokyo, Japan) at 25–95 °Cwith a scanning speed of 20 nm/min.
The sample temperature was controlled by a built-in Peltier
controller. An average of three scans were recorded with a data
pitch of 1 nm and a response time 8 s. The spectra were baseline
corrected using the similar settings.
MRE ([]	 103 deg cm2 dmol1) was calculated using the
following equation,
MREM /10 l c n (Eq. 1)
whereM is themolarmass of the protein (29,000 g/mol),  is the
measured ellipticity in millidegrees, l is the cell path length (0.1
cm), c is the concentration in g/liter (0.2 g/liter), and n is the
number of residues (n 271).
The MRE at 222 nm was plotted against temperature. For
curve fitting, the following Boltzmann sigmoidal equation was
used,
Yobs bottom ((top bottom))/1 exp(TM T)/slope
(Eq. 2)
where Yobs is the MRE, and TM is the temperature at which
MRE is halfway between native and denatured state. Global
analysis of thermal denaturation data were performed using
GraphPad Prism (GraphPad Software, Inc.) by constraining the
shared value of slope for all the data sets. Statistical analysis was
done in Origin (OriginLab). Significance between binding con-
stants was tested using a Z-test for the two population means,
Z 
X1 	 X2

1
2  
2
2
(Eq. 3)
where X1 and X2 are the two binding constants, and 
1 and 
2
are their standard deviations. p values were Bonferroni cor-
rected (***, p 0.001; **, p 0.01; *, p 0.05).
Far-Western blot
The interaction between AQP2 and LIP5 and its dependence
on C-terminal truncation and phosphorylation was studied
using far-Western blot as described by Wu et al. (33). Human
AQP4 was used as negative control. 5 g of each protein was
run on an SDS-PAGE gel and transferred to a nitrocellulose
membrane. The membrane was subjected to four subsequent
30-min incubation steps in buffer (20 mM Tris, pH 7.6, 100 mM
NaCl) containing 6, 3, 1, and 0.1 M guanidine hydrochloride,
followed by a final incubation for 1 h in the same buffer without
guanidine hydrochloride. This allows the transferred proteins
to denature and then re-nature. The membrane was blocked
with 5% (w/v) milk in PBST for 1 h at room temperature fol-
lowed by overnight incubation at 4 °C with interacting protein
LIP5 (0.5g/ml). Themembranewas washedwith PBST buffer
three times for 10 min each to remove unbound LIP5, after
which it was incubated with an rabbit anti-mouse LIP5 anti-
body (20) diluted 1:2000 in PBST containing 3% (w/v) milk for
1 h at room temperature. After washing for 3 	 10 mins in
PBST as above, the membrane was incubated with a secondary
antibody (HRP anti-rabbit IgG, 374-1507; Kirkegaard and Perry
Laboratories) diluted 1:1500 dilution in PBST containing 3%
(w/v) milk 1 h at room temperature. Finally, themembrane was
washed for 3 	 10 min in PBST followed by a single rinse of 5
min with PBS buffer and developed using ECL chemilumines-
cence (GE Healthcare).
Prior to the incubation with LIP5, loading of protein equiva-
lents and equal protein transfer to the blotting membrane was
confirmed by stainingwith Ponceau reagent, as well as antibod-
ies against theHis tag. For Ponceau staining, themembranewas
incubated in Ponceau S solution (Sigma-Aldrich) for 5 min,
after which the stain was removed by washing inMilli Q water.
AQP2 phosphorylation regulates affinity to LIP5
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For staining with antibodies against the His tag, the membrane
was incubated with anti-His antibody (His6 monoclonal anti-
body, 631212 (albumin-free); Clontech), diluted 1:5000 in 3%
milk in PBST for 1 h. After washing for 3 	 10 min each, the
membrane was incubated with a secondary antibody (anti-
mouse IgG, 374-1806; Kirkegaard and Perry Laboratories)
diluted 1:5000 in 3% milk in PBST for 1 h. The membrane was
washed three times for 10 min in PBST followed by a 5-min
wash with PBS and developed using ECL chemiluminescence.
Quantification of far-Western blot signal
The far-Western blot signal from three individual blots was
quantified using the gel analysis softwareGeneTools fromSyn-
gene (Synoptics Ltd.). The blots were quantified by manual
band quantification using the image type absorption. For each
band, an equally sized area was used for quantification, and the
background was subtracted using the inbuilt option in the soft-
ware. All intensities were within the linear range. For each blot,
the signal for wild-type AQP2 was set to 100% and the relative
signal for all other samples was determined. The data were fur-
ther analyzed in Origin (Origin Lab Corporation) by one-way
analysis of variance to calculate the mean and standard devia-
tion and a p-test to explore the statistical significance.
Microscale thermophoresis
For MST experiments using full-WT-AQP2, AQP2 mutants
and AQP4, LIP5 was fluorescently labeled with the amine-re-
active dye (NT-647-NHS) using theMonolithTM protein label-
ing kit RED-NHS (NanoTemper Technologies) according to
the manufacturer’s instructions. Prior to labeling, the LIP5
buffer was exchanged to the labeling buffer supplied by the kit.
After labeling, the protein was eluted into buffer A (20mMTris,
pH 8, 300 mM NaCl, 0.2% OGNPG), which was also used as
assay buffer for MST experiments. Dephosphorylated wild-
type AQP2 (3M), AQP2–256E (30M), AQP2-S261E (30M),
AQP2-S264E (30 M), AQP2-T269E (15 M), and AQP2-
S256E/T269E (60 M) mutants was titrated in a 2:1 dilution
series resulting in 16 different samples. For AQP2-P242 (240)
M and AQP4 (100 M), a 1:1 dilution series was employed.
Starting concentrations are given in parentheses. Each sample
was diluted 2-fold with a solution containing labeled LIP5 at
a concentration of 90 nM (wild-type AQP2, AQP2-P242,
AQP2-S256E/T269E, and AQP4), 30 nM (AQP2-T269E), or 60
nM (AQP2-S256E, AQP2-S261E, and AQP264E). The samples
were transferred toMonolithTMNT.115MST premium coated
capillaries (NanoTemper Technologies), and MST traces were
recorded at room temperature in a Monolith NT.115 (Nano-
Temper Technologies) using the MO.Control software (LED/
excitation power setting 20, MST power setting 40). For all
proteins, MST data were obtained from three individually pre-
pared dilution series. The data were analyzed using Origin.
For the peptide binding experiments, peptides correspond-
ing to residues 244–271 in its unphosphorylated state and sin-
gly phosphorylated at Ser256, Ser261, Ser264, and Thr269 were
purchased from GenScript. Peptide interactions with AQP2
itself was probed using full-length AQP2 that had been labeled
with Alexa Fluor 488 C5-maleimide (Thermo Scientific),
according to the manufacturer’s instructions, overnight at 4 °C
in 20mMTris-HCl, 300mMNaCl, 0.2%OGNPG, pH7.4. Excess
dye was removed using a PD-10 column. A 1.5-fold dilution
series of phosphorylated peptides (10 M) was made, resulting
in 16 samples that weremixed 1:1 with labeled AQP2. The final
concentration of AQP2 was 500 nM in all samples. For binding
experiments against LIP5, a 2-fold dilution series of unphos-
phorylated and phosphorylated peptides (20M)wasmade and
mixed with LIP5 that had been labeled as described for MST
experiments with wild-type AQP2 and AQP2 mutants. MST
traceswere recorded as described above using a LED/excitation
power setting of 40 and MST power setting of 60 for experi-
ments against labeled AQP2. For experiments against labeled
LIP5 the LED/excitation power settings andMSTpower setting
was 20 and 60, respectively. All experiments were measured in
triplicate.
MST data analysis
The MST-data could be fitted to a one-to-one state binding
model using the following equations,
y S1 (S2 S1) LFreeLFreeKd (Eq. 4)
LFree 0.5(LTot PTot Kd) (Kd PTot LTot)2 LTotKd
(Eq. 5)
where S1 is the signal from the unbound state, and S2 the signal
from the complex; LFree and LTot are the free and total mono-
meric [AQP2] concentration, respectively; PTot is the total con-
centration of fluorescently labeled LIP5, and Kd is the dissocia-
tion constant. Fitting was performed in Origin. Significance
between Kd values was tested using a Z-test for two population
means as described under CD data analysis above. Linear
regression analysis for the correlation between logKd and 1/TM
was carried out in GraphPad Prism (GraphPad Software, Inc.),
giving a slope of 5079 2883 and an R2 0.4369.
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